Loading clinical trials...
Loading clinical trials...
Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE): an Invesitgator-initiated, Open-label, Multicenter, Randomized Controlled Trial
Conditions
Interventions
Human albumin infusion at a modified dosage
Human albumin infusion at a routine dosage
+5 more
Locations
1
China
Department of Gastroenterology, General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area)
Shenyang, Liaoning, China
Start Date
June 24, 2025
Primary Completion Date
June 30, 2027
Completion Date
June 30, 2027
Last Updated
August 26, 2025
NCT03515044
NCT03585257
NCT01966419
Lead Sponsor
General Hospital of Shenyang Military Region
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions